← Back to companies
Odyssey Therapeutics
0 open
Boston, Massachusetts, United StatesFounded 2021118+ employeesGrowth raisedGrowthPrivate
Last round: series d · $213M · Sep 2025(4 rounds total)
⚠1 layoff event · Last: Feb 2025
Founded by David Pompliano, Gary Glick
Backed by(30 investors)
Ascenta CapitalGeneral CatalystOrbiMedSR OneDimension CapitalLightspeed Venture PartnersTPGAffinity Asset AdvisorsJeito CapitalWedbush SecuritiesFidelityT. Rowe PriceHBM Healthcare InvestmentsGlobal BioAccess FundCatalio Capital Management
At Odyssey, we are creating next generation precision medicines for patients with cancer and inflammatory diseases with class-leading speed, efficiency and rigor through our highly integrated drug hunting engine. In response to recent recruitment fraud, visit our Careers page to verify all job opportunities and read our guidance on this topic: https://odysseytx.com/careers/
Open Positions at Odyssey Therapeutics (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Odyssey Therapeutics?
